Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders?
The purpose of this study was to compare outcomes assessed in extant randomized controlled trials (RCTs) to outcomes that stakeholders expect from survivorship care plans (SCPs). To facilitate the transition from active treatment to follow-up care for the 15.5 million US cancer survivors, many organizations require SCP use. However, results of several RCTs of SCPs’ effectiveness have been null, possibly because they have evaluated outcomes on which SCPs should be expected to have limited influence. Stakeholders (e.g., survivors, oncologists) may expect outcomes that differ from RCTs’ outcomes.
We identified RCTs’ outcomes using a PubMed literature review. We identified outcomes that stakeholders expect from SCPs using semistructured interviews with stakeholders in three healthcare systems in the USA and Canada. Finally, we mapped RCTs’ outcomes onto stakeholder-identified outcomes.
RCT outcomes did not fully address outcomes that stakeholders expected from SCPs, and RCTs assessed outcomes that stakeholders did not expect from SCPs. RCTs often assessed outcomes only from survivors’ perspectives.
RCTs of SCPs’ effectiveness have not assessed outcomes that stakeholders expect. To better understand SCPs’ effectiveness, future RCTs should assess outcomes of SCP use that are relevant from the perspective of multiple stakeholders.
Implications for Cancer Survivors
SCPs’ effectiveness may be optimized when used with an eye toward outcomes that stakeholders expect from SCPs. For survivors, this means using SCPs as a map to guide them with respect to what kind of follow-up care they should seek, when they should seek it, and from whom they should seek it.
KeywordsSurvivorship care plans Stakeholders Outcomes Randomized controlled trials
This publication was supported by Grant Number 15014 from the Cancer Research Network 2015 Opportunity Fund Program and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR001109. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the awardee, subawardee, the Cancer Research Network, or the National Institutes of Health.
Compliance with ethical standards
The Institutional Review Board at the University of North Carolina at Chapel Hill exempted the study from human subjects review. The Research Ethics Board at NSHA and the Institutional Review Board at KPSC approved the study.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 10.Institute of Medicine. In: Levit LA, et al., editors. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: National Academy of Sciences; 2013.Google Scholar
- 11.National Cancer Survivorship Resource Center. Systems policy and practice: clinical survivorship care. Atlanta: American Cancer Society; 2011.Google Scholar
- 13.Commission on Cancer, American Cancer Society. Cancer program standards 2012: ensuring patient-centered care. Atlanta: American Cancer Society; 2012.Google Scholar
- 23.Nicolaije KA, Ezendam NP, Pijnenborg JM, et al. Paper-based survivorship care plans may be less helpful for cancer patients who search for disease-related information on the internet: results of the Registrationsystem Oncological Gynecology (ROGY) care randomized trial. J Med Internet Res. 2016;18(7):e162.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Glaser BG, Strauss AL. Awareness of dying. Chicago: Aldine; 1965.Google Scholar
- 31.Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine; 1967.Google Scholar
- 32.Glaser BG. Basics of grounded theory analysis: emergence vs. forcing. Mill Valley: Sociology Press; 1992.Google Scholar
- 33.What is patient experience? Content last reviewed March 2017. Agency for Healthcare Research and Quality, Rockville. http://www.ahrq.gov/cahps/about-cahps/patient-experience/index.html.
- 42.Patient Centered Outcomes Research Institute (PCORI). https://www.pcori.org/about-us.
- 43.Canadian Institutes of Health Research. Canada’s strategy for patient-oriented research. http://www.cihr-irsc.gc.ca/e/44000.html.
- 44.Chadder J, Zomer S, on behalf of the Canadian Partnership Against Cancer and provincial investigators. Experiences of cancer patients in transition. Canadian Partnership Against Cancer System Performance Initiative and Person-Centred Perspective Grant ($1,550,000; 2015–2017).Google Scholar